Diagnostics

Alpha-synuclein aggregation in the olfactory mucosa of patients with isolated RBD vs. PD 2:54
Alpha-synuclein aggregation in the olfactory mucosa of patients with isolated RBD vs. PD
Ambra Stefani • 23 Jun 2021
MicroRNA panel for multiple sclerosis: potential biomarkers? 1:12
MicroRNA panel for multiple sclerosis: potential biomarkers?
Bárbara Guerra Leal • 1 Jul 2021
Research needs in seronegative myasthenia gravis 1:37
Research needs in seronegative myasthenia gravis
Hakan Cetin • 23 Jun 2021
Future challenges for MS research: progressive disease 2:12
Future challenges for MS research: progressive disease
Mar Tintoré • 7 Jun 2021
How to individualize MS treatment decisions? 12:15
How to individualize MS treatment decisions?
Mar Tintoré • 7 Jun 2021
Future research in CBI: work-up & preventive strategies for incidental CBI 0:47
Future research in CBI: work-up & preventive strategies for incidental CBI
Thomas Meinel • 7 Jun 2021
Covert brain infarction: incidental findings 1:18
Covert brain infarction: incidental findings
Thomas Meinel • 7 Jun 2021
Covert brain infarction: a silent pandemic 1:10
Covert brain infarction: a silent pandemic
Thomas Meinel • 7 Jun 2021
MS research from EAN 2021 2:11
MS research from EAN 2021
Massimo Filippi • 17 Jun 2021
Future evolutions of the McDonald criteria 2:11
Future evolutions of the McDonald criteria
Massimo Filippi • 17 Jun 2021
Impact of sex and gender on migraine management 2:06
Impact of sex and gender on migraine management
Elena Lebedeva • 7 Jun 2021
Association of chronic covert brain infarction with etiology of first-ever acute ischemic stroke 2:29
Association of chronic covert brain infarction with etiology of first-ever acute ischemic stroke
Thomas Meinel • 7 Jun 2021
Comparison of the 2017 and 2010 revisions of the McDonald criteria: MAGNIMS study 3:35
Comparison of the 2017 and 2010 revisions of the McDonald criteria: MAGNIMS study
Massimo Filippi • 17 Jun 2021
CBI phenotypes in first-ever ischemic stroke patients 1:12
CBI phenotypes in first-ever ischemic stroke patients
Thomas Meinel • 7 Jun 2021
Biomarkers as a diagnostic tool for Alzheimer’s disease 1:53
Biomarkers as a diagnostic tool for Alzheimer’s disease
Wiesje van der Flier • 8 Jun 2021
Tools for the diagnosis of Alzheimer’s disease 1:14
Tools for the diagnosis of Alzheimer’s disease
Wiesje van der Flier • 8 Jun 2021
The content of VJNeurology is intended for healthcare professionals